CX3CR1 and Stroke: However, it should be noted that minocycline is not microglia-specific and genetic deletion of Cx3Cr1 only alters rather than completely abolishes microglial behavior; therefore, these and other observational data could not unequivocally conclude that microglia cause BBB disruption after stroke.